Expectations trend
FY2028 · fiscal year ending 2028-09-30 · fmp
Mitek Systems, Inc. (MITK)
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-05
$16.93-11.31%
Close 2026-11-05 · 1-day change
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
1.42 → 1.41 EPS · FY ending Sep 30, 2028 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for MITK yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Adjusted EBITDA margin near 29%-32% | Profit margins improved, with EBITDA margin guidance raised to 29%-32%. | Intact | Adjusted EBITDA margin falls below 27% in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: “- August 6, 2026 - Mitek Systems, Inc. (NASDAQ: MITK, www.miteksystems.com , “Mitek” or the “Company”), a global leader in digital identity verification and fraud prevention, today reported financial results for its third quarter ended June 30, 2026 and raised its revenue and adjusted EBITDA margin guidance range for the fiscal year ending September 30, 2026 (“fiscal 2026”).” “• Adjusted EBITDA margin was 38.5%, compared to 28.6% a year ago.” |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-09-30 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Dec 10, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a growth-oriented technology business with strong recent financial performance, rather than a proven durable compounder: it remains loss-making overall and its risk is elevated. The long-term thesis is intact, though confidence has eased from high to medium.
Valuation evidence is mixed: MITK is described as cheap versus peers, while a separate measure shows a 51% premium versus peers. The expectations gap is negative, suggesting expectations may be demanding; the overall priced-in assessment is tagged justified, with low fragility.
Near-term results have been strong: second-quarter revenue grew 18% year over year, Fraud & Identity SaaS revenue grew 37%, and adjusted EBITDA margin rose to 38.5% from 28.6%. Management raised fiscal 2026 revenue and margin guidance, but the company remains loss-making, and a smaller size plus recent peer misses create some execution risk.
Over the next few quarters, the key test is whether management can sustain growth and margins after raising guidance. A guidance cut would damage credibility, while easing rates or steadier results from large technology peers could support the sector backdrop.
For the next 1 to 3 years, the thesis rests on continued execution in revenue growth, SaaS expansion, and profitability, with the recent president transition and elevated risk worth watching. The business setup remains constructive, but confidence is medium. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Maintain strong balance sheet after repaying $155M convertible notes | The company repaid $155M in convertible notes, strengthening its balance sheet. | Intact | New debt or refinancing increases leverage materially after note repayment | Debt $0 vs $155M target Mitek Systems repaid $155.25M in 0.750% Convertible Senior Notes in full on February 1, 2026. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth at or above 8.9% annually | A primary condition in Mitek Systems, Inc.'s published investment case. The stated target is >=8.9% YoY revenue growth. | Intact | YoY revenue growth falls below ~7% in FY26 | Revenue growth: 18.17% FY2026-Q3; GAAP. Published target: >=8.9% YoY revenue growth. Annual target cannot be compared with a quarterly or TTM observation. Aug 6, 202618.170089 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.42 → $1.41 · observed estimates
$0.24B → $0.24B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-10-01 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-02 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-03 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-04 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-05 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-06 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-07 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-08 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-09 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-10 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-11 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-12 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-13 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-14 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-15 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-16 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-17 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-18 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-19 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-20 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-21 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-22 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-23 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-24 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-25 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-26 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-27 | $1.42 | $236,598,550 | 1 / 1 |
| 2026-10-28 | $1.41 | $237,200,000 | 1 / 1 |
| 2026-10-29 | $1.41 | $237,200,000 | 1 / 1 |
| 2026-10-30 | $1.41 | $237,200,000 | 1 / 1 |
| 2026-10-31 | $1.41 | $237,200,000 | 1 / 1 |
| 2026-11-01 | $1.41 | $237,200,000 | 1 / 1 |
| 2026-11-02 | $1.41 | $237,200,000 | 1 / 1 |
| 2026-11-03 | $1.41 | $237,200,000 | 1 / 1 |
| 2026-11-04 | $1.41 | $237,200,000 | 1 / 1 |
| 2026-11-05 | $1.41 | $237,200,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 5 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.